This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Respiratory Failure
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The aim of the study is to assess, in patients with acute hypoxemic respiratory failure, the short term physiologic effects of the high flow oxygen nasal therapy (Optiflow), in term of inspiratory muscle effort, gas exchange, comfort and dyspnea

Provided treatments

  • Procedure: O2stand
  • Procedure: CPAP
  • Procedure: Optiflow

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01056952. The sponsor of the trial is University Hospital, Bordeaux and it is looking for 12 volunteers for the current phase.
Official trial title:
Physiologic Effects of High Flow Nasal Therapy in Patients With Acute Hypoxemic Respiratory Failure